Media item displaying Adam Pan

Adam Pan

Associate

[email protected]

202.434.5910

Adam received his J.D. from Yale Law School, where he served as Co-Editor-in-Chief for the Yale Journal of Health Policy, Law, and Ethics and the Yale Journal of Law and Technology. Prior to attending Yale, Adam received his Ph.D. from the Massachusetts Institute of Technology for research on computational X-ray phase contrast imaging of human atherosclerotic disease. Adam clerked for Judge Timothy B. Dyk of the United States Court of Appeals for the Federal Circuit.

Publications

  • Zachary E. Shapiro, Chaarushena Deb, Caroline Lawrence, Allison Rabkin Golden, Jaclyn Wilner, Allison Durkin, Zoe M. Adams, Wenqing Zhao, Keturah James, Adam Pan, Megan S. Wright, and Joseph J. Fins, Olmstead Enforcements for Moderate to Severe Brain Injury: The Pursuit of Civil Rights Through the Application of Law, Neuroscience, and Ethics, 95 TUL. L. REV. 525 (2021).
  • Megan S. Wright, Keturah James, Adam Pan & Joseph Fins, When Biomarkers Are Not Enough: FDA Evaluation of Effectiveness of Neuropsychiatric Devices for Disorders of Consciousness, 21 Stanford Tech. L.R. 276 (2018).
  • Adam Pan & Katherine L. Kraschel, CRISPR Diagnostics: Underappreciated Uses in Perinatology, 42 Seminars in Perinatology 525 (2018).
  • Zachary E. Shapiro, Adam Pan, Keturah James, Megan S. Wright & Joseph J. Fins, Nothing Generic About It: Promoting Therapeutic Access by Overcoming Regulatory and Legal Barriers to a Robust Generic Medical Device Market, 98 N.C. L. Rev. 595 (2020).